These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 28005346)

  • 1. Identification of Crucial Amino Acid Residues Involved in Agonist Signaling at the GPR55 Receptor.
    Lingerfelt MA; Zhao P; Sharir HP; Hurst DP; Reggio PH; Abood ME
    Biochemistry; 2017 Jan; 56(3):473-486. PubMed ID: 28005346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A selective antagonist reveals a potential role of G protein-coupled receptor 55 in platelet and endothelial cell function.
    Kargl J; Brown AJ; Andersen L; Dorn G; Schicho R; Waldhoer M; Heinemann A
    J Pharmacol Exp Ther; 2013 Jul; 346(1):54-66. PubMed ID: 23639801
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of the GPR55 agonist binding site using a novel set of high-potency GPR55 selective ligands.
    Kotsikorou E; Madrigal KE; Hurst DP; Sharir H; Lynch DL; Heynen-Genel S; Milan LB; Chung TD; Seltzman HH; Bai Y; Caron MG; Barak L; Abood ME; Reggio PH
    Biochemistry; 2011 Jun; 50(25):5633-47. PubMed ID: 21534610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the GPR55 antagonist binding site using a novel set of high-potency GPR55 selective ligands.
    Kotsikorou E; Sharir H; Shore DM; Hurst DP; Lynch DL; Madrigal KE; Heynen-Genel S; Milan LB; Chung TD; Seltzman HH; Bai Y; Caron MG; Barak LS; Croatt MP; Abood ME; Reggio PH
    Biochemistry; 2013 Dec; 52(52):9456-69. PubMed ID: 24274581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modulation of L-α-lysophosphatidylinositol/GPR55 mitogen-activated protein kinase (MAPK) signaling by cannabinoids.
    Anavi-Goffer S; Baillie G; Irving AJ; Gertsch J; Greig IR; Pertwee RG; Ross RA
    J Biol Chem; 2012 Jan; 287(1):91-104. PubMed ID: 22027819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The GPR55 ligand L-alpha-lysophosphatidylinositol promotes RhoA-dependent Ca2+ signaling and NFAT activation.
    Henstridge CM; Balenga NA; Ford LA; Ross RA; Waldhoer M; Irving AJ
    FASEB J; 2009 Jan; 23(1):183-93. PubMed ID: 18757503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The GPCR-associated sorting protein 1 regulates ligand-induced down-regulation of GPR55.
    Kargl J; Balenga NA; Platzer W; Martini L; Whistler JL; Waldhoer M
    Br J Pharmacol; 2012 Apr; 165(8):2611-9. PubMed ID: 21718301
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lysophosphatidylinositol induces rapid phosphorylation of p38 mitogen-activated protein kinase and activating transcription factor 2 in HEK293 cells expressing GPR55 and IM-9 lymphoblastoid cells.
    Oka S; Kimura S; Toshida T; Ota R; Yamashita A; Sugiura T
    J Biochem; 2010 May; 147(5):671-8. PubMed ID: 20051382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The actions and metabolism of lysophosphatidylinositol, an endogenous agonist for GPR55.
    Yamashita A; Oka S; Tanikawa T; Hayashi Y; Nemoto-Sasaki Y; Sugiura T
    Prostaglandins Other Lipid Mediat; 2013 Dec; 107():103-16. PubMed ID: 23714700
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A homology modeling study toward the understanding of three-dimensional structure and putative pharmacological profile of the G-protein coupled receptor GPR55.
    Elbegdorj O; Westkaemper RB; Zhang Y
    J Mol Graph Model; 2013 Feb; 39():50-60. PubMed ID: 23220281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacology of GPR55 in yeast and identification of GSK494581A as a mixed-activity glycine transporter subtype 1 inhibitor and GPR55 agonist.
    Brown AJ; Daniels DA; Kassim M; Brown S; Haslam CP; Terrell VR; Brown J; Nichols PL; Staton PC; Wise A; Dowell SJ
    J Pharmacol Exp Ther; 2011 Apr; 337(1):236-46. PubMed ID: 21233197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 2-Arachidonoyl-sn-glycero-3-phosphoinositol: a possible natural ligand for GPR55.
    Oka S; Toshida T; Maruyama K; Nakajima K; Yamashita A; Sugiura T
    J Biochem; 2009 Jan; 145(1):13-20. PubMed ID: 18845565
    [TBL] [Abstract][Full Text] [Related]  

  • 13. What is the natural ligand of GPR55?
    Okuno T; Yokomizo T
    J Biochem; 2011 May; 149(5):495-7. PubMed ID: 21324983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. GPR55, a lysophosphatidylinositol receptor with cannabinoid sensitivity?
    Nevalainen T; Irving AJ
    Curr Top Med Chem; 2010; 10(8):799-813. PubMed ID: 20370712
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The LPI/GPR55 axis enhances human breast cancer cell migration via HBXIP and p-MLC signaling.
    Zhou XL; Guo X; Song YP; Zhu CY; Zou W
    Acta Pharmacol Sin; 2018 Mar; 39(3):459-471. PubMed ID: 29188802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lysophosphatidylinositol causes neurite retraction via GPR55, G13 and RhoA in PC12 cells.
    Obara Y; Ueno S; Yanagihata Y; Nakahata N
    PLoS One; 2011; 6(8):e24284. PubMed ID: 21904624
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The GPR 55 agonist, L-α-lysophosphatidylinositol, mediates ovarian carcinoma cell-induced angiogenesis.
    Hofmann NA; Yang J; Trauger SA; Nakayama H; Huang L; Strunk D; Moses MA; Klagsbrun M; Bischoff J; Graier WF
    Br J Pharmacol; 2015 Aug; 172(16):4107-18. PubMed ID: 25989290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GPR55-dependent and -independent ion signalling in response to lysophosphatidylinositol in endothelial cells.
    Bondarenko A; Waldeck-Weiermair M; Naghdi S; Poteser M; Malli R; Graier WF
    Br J Pharmacol; 2010 Sep; 161(2):308-20. PubMed ID: 20735417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modulation of l-α-lysophosphatidylinositol/GPR55 MAP kinase signalling by CB2 receptor agonists: identifying novel GPR55 inhibitors.
    Anavi-Goffer S; Irving AJ; Ross RA
    J Basic Clin Physiol Pharmacol; 2016 May; 27(3):303-10. PubMed ID: 27089417
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of PI3K/Akt/GSK3β signaling cascade through G protein-coupled receptor 55 (GPR55) activation: Prenatal lysophosphatidylinositol attenuates valproic acid-induced synaptic abnormalities and mitochondrial dysfunction.
    Ahmed S; Abir AH; Sharmin O; Khurshid N; Akter A; Nakshy NT; Hasan MM; Yesmine S; Rahman M
    Life Sci; 2023 Dec; 334():122195. PubMed ID: 37866808
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.